Speaker illustration

Associate Professor Martin Bauer

Medical University of Vienna, Vienna (Austria)

SAIT - Specific Active immunotherapy (SAIT) against PCSK9 is safe and lowers circulating LDL-C in humans

Event: ESC Congress 2018

Topic: Lipid-Lowering Agents

Session: Late Breaking Pharmacological Science

Thumbnail